PIK3CA and breast carcinoma: Gain-of-function mutations in PI3K [i.e., mutations in the p110 catalytic subunit of PI3K (PIK3CA)] thus enhance the PI(3,4,5)P3 signalling pathway and are frequently found in breast cancers and other cancers2, 3.